{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:57:38Z","timestamp":1780631858531,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":3191,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1093\/annonc\/mdq412","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T01:44:42Z","timestamp":1283391882000},"page":"712-717","source":"Crossref","is-referenced-by-count":57,"title":["Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study"],"prefix":"10.1016","volume":"22","author":[{"given":"M.","family":"Merlano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Benasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Corv\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Colantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vigna-Taglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Numico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Crosetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lo Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Violante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq412_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an up-date on 93 randomized trials of 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdq412_bb0020","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.ijrobp.2007.04.088","article-title":"Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update","volume":"69","author":"Pignon","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0025","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","article-title":"Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy","volume":"10","author":"Argiris","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdq412_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S0022215106002374","article-title":"Evaluation of epidermoid growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue mycroarrays","volume":"121","author":"Tsiambas","year":"2007","journal-title":"J Laryngol Otol"},{"key":"10.1093\/annonc\/mdq412_bb0035","first-page":"589","article-title":"Skp2, p27\/Kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implication","volume":"20","author":"Corracedo","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1093\/annonc\/mdq412_bb0040","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of cancerogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdq412_bb0045","first-page":"2884","article-title":"Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas","volume":"5","author":"Akimoto","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdq412_bb0050","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdq412_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0060","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2003.08.035","article-title":"Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies","volume":"58","author":"Milas","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0065","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Rubin Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq412_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq412_bb0075","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq412_bb0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","article-title":"Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1634\/theoncologist.11-2-146","article-title":"Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?","volume":"11","author":"Merlano","year":"2006","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq412_bb0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","article-title":"Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck","volume":"88","author":"Merlano","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq412_bb0095","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/1097-0142(20011201)92:11<2856::AID-CNCR10132>3.0.CO;2-6","article-title":"Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck","volume":"92","author":"Corv\u00f2","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq412_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/djn460","article-title":"Phase III randomized trial on larynx preservation comparing sequential versus alternating chemotherapy and radiotherapy","volume":"101","author":"Lefebvre","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq412_bb0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3322\/canjclin.55.4.242","article-title":"TNM staging of cancers of the head and neck: striving for uniformity among diversity","volume":"55","author":"Patel","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdq412_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00202-4","article-title":"Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience","volume":"56","author":"Gregoire","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gregoire","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0120","unstructured":"ICRU. Prescribing, Recording and Reporting Photon Beam Therapy. Report 50. Washington, DC: International Commission on Radiation Units and Measurements 1993"},{"key":"10.1093\/annonc\/mdq412_bb0125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0360-3016(99)00319-3","article-title":"Critical appraisal of a conformal head and neck cancer irradiation avoiding electron beams and field matching","volume":"45","author":"Fogliata","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1093\/annonc\/mdq412_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdq412_bb0145","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2007.05.063","article-title":"Ultrathin hydrocolloid dressing in skin damaged from alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (GONO AlteRCC Italian trial): in regard to Macmillan et al","volume":"69","author":"Russi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1188\/08.CJON.283-290","article-title":"An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors","volume":"12","author":"Eaby","year":"2008","journal-title":"Clin J Oncol Nurs"},{"key":"10.1093\/annonc\/mdq412_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000112795","article-title":"Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results","volume":"72","author":"Boone","year":"2007","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdq412_bb0160","first-page":"34","article-title":"Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae","volume":"21","author":"Wagner","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"10.1093\/annonc\/mdq412_bb0165","first-page":"4","article-title":"Clinical presentation and pathophysiology of EGFRI dermatologic toxicities","volume":"21","author":"Mitchell","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"10.1093\/annonc\/mdq412_bb0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdq412_bb0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/14737140.6.3.395","article-title":"Future chemotherapy and radiotherapy options in head and neck cancer","volume":"6","author":"Merlano","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1093\/annonc\/mdq412_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2008.09.002","article-title":"Current state-of-the-art for concurrent chemoradiation","volume":"19","author":"Bernier","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0185","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijrobp.2006.05.059","article-title":"Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule","volume":"66","author":"Numico","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdq412_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2008.04.002","article-title":"A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck","volume":"89","author":"Benasso","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/annonc\/mdh138","article-title":"Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck","volume":"15","author":"Benasso","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2004.11.007","article-title":"Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial","volume":"75","author":"Merlano","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0205","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0210","first-page":"142","article-title":"High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC Institutes","volume":"92","author":"Giro","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0215","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","article-title":"Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer","volume":"90","author":"Pryor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdq412_bb0220","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq412_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","article-title":"Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab","volume":"184","author":"B\u00f6lke","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1093\/annonc\/mdq412_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.radonc.2009.03.001","article-title":"Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: \u201ckoebner-phenomenon\u201d or radio-dermatitis?","volume":"92","author":"Merlano","year":"2009","journal-title":"Radiother Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419386107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/3\/712\/718925\/mdq412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:26:47Z","timestamp":1624699607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419386107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0923753419386107"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq412","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}